Skip to content

Atypical Antipsychotics in the Treatment of Affective Symptoms of Schizophrenia in Hungary

Atypical Antipsychotics in the Treatment of Affective Symptoms of Schizophrenia in Hungary.

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT01534936
Acronym
AFFECT
Enrollment
2153
Registered
2012-02-17
Start date
2012-02-29
Completion date
2012-12-31
Last updated
2012-12-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Affective Symptoms, Schizophrenia

Keywords

schizophrenia, atypical antipsychotics, depressive symptoms

Brief summary

This is a noninterventional observational study lead amongst psychiatrists, to assess the the overall status of schizophrenic outpatients with affective symptoms treated with atypical antipsychotics.

Detailed description

Atypical antipsychotics in the treatment of affective symptoms of schizophrenia in Hungary

Interventions

None listed

Sponsors

AstraZeneca
Lead SponsorINDUSTRY

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Schizophrenic outpatients diagnosis based on DSM -IV above 18 years of age with affective symptoms. * Atypical antipsychotic treatment at least for a month before study inclusion.

Exclusion criteria

* Pregnancy. * Hepatic disease. * Diabetes mellitus. * Severe cerebro- or cardiovascular disease.

Design outcomes

Primary

MeasureTime frameDescription
Change from baseline on clinical global impression scale up to 6 months of schizophrenic outpatients with affective symptoms.3 and 6 monthsThe Clinical Global Impression Scale (CGI) is a brief clinician-rated instrument. The CGI severity of illness measure (CGI-S) is rated from 1 (normal, not at all ill) to 7 (among the most extremely ill patients). The CGI global improvement measure (CGI-I) is rated from 1 (very much improved) to 7 (very much worse). 0 stands for not assessed. Means and standard deviations (SD) for CGI-S(baseline), CGI-S (1.visit) CGI-S (2.visit) and for CGI-I will be calculated.

Secondary

MeasureTime frameDescription
Description of the relation between and the change of affective symptoms and overall clinical status.3 and 6 months
Assessment of the efficacy of different atypical antipsychotics in the treatment of schizophrenia with affective symptoms measured by the difference in CGI-S (CGI severity of illness measure) and CGI-I (CGI global improvement measure).From baseline up to 6 monthsThe Clinical Global Impression Scale (CGI) is a brief clinician-rated instrument. The CGI severity of illness measure (CGI-S) is rated from 1 (normal, not at all ill) to 7 (among the most extremely ill patients). The CGI global improvement measure (CGI-I) is rated from 1 (very much improved) to 7 (very much worse). 0 stands for not assessed.
Assessment of the efficacy of different atypical antipsychotics in the treatment of schizophrenia with affective symptoms measured by the difference in Raskin Scale.From baseline up to 6 monthsRaskin scale is rated from 1 not at all to 5 very much , in three aspects: verbal report, behaviour, secondary symptoms of depression. Above 9 (the sum points) is considered moderate depression.

Countries

Hungary

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026